IMMUNOME INC (IMNM)
US45257U1088 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.018M | 9.602M -31.50% | 3.829M -60.12% | 18.962M 395.22% | 78.609M 314.56% | 229.13M 191.48% | 349.17M 52.39% | 567.5M 62.53% | 873.94M 54.00% | |||
| EBITDA YoY % growth | -24.44M -112.52% | -36.48M -49.26% | -28.271M 22.50% | -259.08M -816.42% | -199.92M 22.83% | -178.5M 10.71% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -25.2M -105.55% | -36.9M -46.43% | -28.728M 22.15% | -273.337M -851.47% | -211.584M 22.59% | -223.248M -5.51% | -174.827M 21.69% | -67.326M 61.49% | 7.505M 111.15% | 169.79M 2,162.36% | 376.25M 121.60% | |
| Operating Margin | N/A | N/A | -204.94% | -2,846.67% | -5,525.83% | -1,177.34% | -222.40% | -29.38% | 2.15% | 29.92% | 43.05% | |
| EPS YoY % growth | -2.16 75.46% | -3.09 -43.06% | N/A 67.94% | -4.47 -350.78% | -3.06 31.58% | -3.05 0.10% | -1.73 43.31% | -0.38 78.19% | 1.01 368.92% | 2.32 128.64% | 3.51 51.43% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.67 84.04% | -0.77 69.42% | -0.79 -60.29% | -0.81 -20.76% | -0.85 -26.22% | -0.88 -14.37% | -0.87 -10.91% | -0.90 -10.82% | -0.83 1.87% | -0.96 -9.82% | -0.92 -6.09% | -0.82 8.65% |
| Revenue Q2Q % growth | 3.219M -15.87% | -100.00% | -100.00% | -100.00% | -100.00% | 300.39K | 1.681M | 6.943M | 11.076M | 15.96M 5,213.09% | ||
| EBITDA Q2Q % growth | -48.96M -265.54% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -46.029M -232.32% | -43.996M -116.25% | -45.73M -35.71% | -47.26M -7.86% | -49.844M -8.29% | -44.166M -0.39% | -47.022M -2.83% | -49.776M -5.32% | -52.53M -5.39% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.67 -286.39% | -0.57 | -0.10 | -17.65% |
| Q2 2024 Q2Q % growth | -0.49 -6.52% | -0.40 | -0.09 | -22.13% |
| Q1 2024 Q2Q % growth | -2.51 -617.14% | -0.71 | -1.80 | -254.68% |
| Q4 2023 Q2Q % growth | -4.22 -559.37% | -0.29 | -3.93 | -1,360.22% |
| Q3 2023 Q2Q % growth | 76.88% | -0.17 | % | |
| Q2 2023 Q2Q % growth | -0.46 37.84% | -0.16 | -0.30 | -181.86% |
| Q1 2023 Q2Q % growth | -0.35 63.54% | 0.60 | -0.95 | -158.66% |
| Q4 2022 Q2Q % growth | -0.64 5.88% | -0.69 | 0.05 | 7.04% |
| Q3 2022 Q2Q % growth | -0.75 -15.38% | -0.78 | 0.03 | 3.25% |
| Q2 2022 Q2Q % growth | -0.74 -60.87% | -0.77 | 0.03 | 3.27% |
| Q1 2022 Q2Q % growth | -0.96 -159.46% | -0.70 | -0.26 | -36.40% |
| Q4 2021 Q2Q % growth | -0.68 -70.00% | -0.83 | 0.15 | 17.70% |
| Q3 2021 Q2Q % growth | -0.65 91.36% | -0.51 | -0.14 | -27.45% |
| Q2 2021 Q2Q % growth | -0.46 | -0.40 | -0.06 | -15.64% |
| Q1 2021 Q2Q % growth | -0.37 | -0.42 | 0.05 | 11.53% |
| Q4 2020 Q2Q % growth | -0.40 | -0.30 | -0.10 | -35.23% |
| Q3 2020 Q2Q % growth | -7.52 | -0.39 | -7.13 | -1,840.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.91M -18.49% | 2.176M | 734K | 33.73% |
| Q2 2024 Q2Q % growth | 2.364M -44.55% | 2.601M | -237K | -9.11% |
| Q1 2024 Q2Q % growth | 1.029M | 2.856M | -1.827M | -63.97% |
| Q4 2023 Q2Q % growth | 3.826M | 2.111M | 1.715M | 81.24% |
| Q2 2021 Q2Q % growth | 3.857M | -3.857M | -100.00% | |
| Q1 2021 Q2Q % growth | 2.639M | -2.639M | -100.00% | |
| Q4 2020 Q2Q % growth | 2.142M | -2.142M | -100.00% | |
| Q3 2020 Q2Q % growth | 398.31K | -398.31K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -40.12% | -4.07% | -7.32% |
| Revenue | 0% | 17.74% | 0.24% | 12.08% |